Bayer's Finerenone Stacks Up More CV Benefit Data Ahead Of Potential Approval

 
• By Jessica Merrill
  
Heart health
Bayer's finerenone showed a significant benefit in a CV outcomes trial • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Genitourinary

More from Therapeutic Category